scispace - formally typeset
P

Paul Kind

Researcher at University of Leeds

Publications -  173
Citations -  21074

Paul Kind is an academic researcher from University of Leeds. The author has contributed to research in topics: Population & EQ-5D. The author has an hindex of 53, co-authored 169 publications receiving 17687 citations. Previous affiliations of Paul Kind include University of York & Charing Cross Hospital.

Papers
More filters
Journal ArticleDOI

Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)

TL;DR: A 5-level version of the EQ-5D has been developed by the EuroQol Group and further testing is required to determine whether the new version improves sensitivity and reduces ceiling effects.
Journal ArticleDOI

Interim Scoring for the EQ-5D-5L: Mapping the EQ-5D-5L to EQ-5D-3L Value Sets

TL;DR: The nonparametric model was preferred for its simplicity while performing similarly to the other models, and being independent of the value set that is used, it can be applied to transform any EQ-5D-3L value set into EQ- 5D-5L index values.
Journal ArticleDOI

Variations in population health status: results from a United Kingdom national questionnaire survey.

TL;DR: The EQ-5D questionnaire is a practical way of measuring the health of a population and of detecting differences in subgroups of the population and it highlights variations in states of health which are consistent with previously published results.
Journal ArticleDOI

Measuring health-related quality of life in rheumatoid arthritis: validity, responsiveness and reliability of EuroQol (EQ-5D).

TL;DR: EQ-5D is of potential use as an outcome measure in clinical trials, audit and health economic studies, but further work is required on its performance in other clinical contexts and on the interpretation of the utility values.
Journal ArticleDOI

The time trade-off method: results from a general population study.

TL;DR: The paper shows that valuations for severe health states appear to be affected by the age and the sex of the respondent; those aged 18-59 have higher valuations than those aged 60 or over and men have highervaluations than women.